167 related articles for article (PubMed ID: 36645520)
1. Retrospective cohort study of scalp cooling in breast cancer patients.
Rose L; Schnell PM; Radcliff L; Lustberg M; Dulmage B
Support Care Cancer; 2023 Jan; 31(2):118. PubMed ID: 36645520
[TBL] [Abstract][Full Text] [Related]
2. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
[TBL] [Abstract][Full Text] [Related]
3. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
5. Scalp cooling: management option for chemotherapy-induced alopecia.
Roe H
Br J Nurs; 2014 Sep 11-24; 23(16):S4, S6, S8 passim. PubMed ID: 25203854
[TBL] [Abstract][Full Text] [Related]
6. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
[TBL] [Abstract][Full Text] [Related]
7. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
[TBL] [Abstract][Full Text] [Related]
8. Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
Dilawari A; Gallagher C; Alintah P; Chitalia A; Tiwari S; Paxman R; Adams-Campbell L; Dash C
Oncologist; 2021 Apr; 26(4):292-e548. PubMed ID: 33512741
[TBL] [Abstract][Full Text] [Related]
9. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
Chan A; Bauwens A; Pontre S; Jackson S; McGlone F; Ernenwein T; Chih J; Reid C
Breast; 2018 Oct; 41():127-132. PubMed ID: 30048865
[TBL] [Abstract][Full Text] [Related]
11. Scalp cooling to prevent chemotherapy-induced alopecia.
Silva GB; Ciccolini K; Donati A; Hurk CVD
An Bras Dermatol; 2020; 95(5):631-637. PubMed ID: 32622629
[TBL] [Abstract][Full Text] [Related]
12. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
Prochilo T; Huscher A; Andreis F; Mirandola M; Zaina E; Pomentale B; Pedrali C; Zanotti L; Mutti S; Zaniboni A
Rev Recent Clin Trials; 2019; 14(1):66-71. PubMed ID: 30457055
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review.
Novice T; Novice M; Portney D; Goyert J; Henry NL; Jeruss JS; Burness ML
Support Care Cancer; 2022 Oct; 30(10):8349-8355. PubMed ID: 35870021
[TBL] [Abstract][Full Text] [Related]
14. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
[TBL] [Abstract][Full Text] [Related]
15. Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Rugo HS; Voigt J
Clin Breast Cancer; 2018 Feb; 18(1):19-28. PubMed ID: 28939291
[TBL] [Abstract][Full Text] [Related]
16. Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy.
Ron IG; Kalmus Y; Kalmus Z; Inbar M; Chaitchik S
Support Care Cancer; 1997 Mar; 5(2):136-8. PubMed ID: 9069614
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy, Alopecia, and Scalp Cooling Systems.
Amarillo D; de Boni D; Cuello M
Actas Dermosifiliogr; 2022 Mar; 113(3):278-283. PubMed ID: 35526920
[TBL] [Abstract][Full Text] [Related]
18. Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention.
Villarreal-Garza C; Mesa-Chavez F; Garza-Ledezma MRA; Peña-Curiel O; Martinez-Cannon BA; Canavati-Marcos M; Cardona-Huerta S
Breast Cancer Res Treat; 2021 Jan; 185(2):453-458. PubMed ID: 33125621
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
[TBL] [Abstract][Full Text] [Related]
20. Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results.
Coolbrandt A; T'Jonck A; Blauwens K; Dejaeger E; Neven P; Punie K; Vancoille K; Wildiers H
Breast Cancer Res Treat; 2021 Apr; 186(3):715-722. PubMed ID: 33452953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
